Pharmacokinetics of liposomal amphotericin B during extracorporeal albumin dialysis

Helene Vogelsinger1, Michael Joannidis, Jordan Kountchev

  • 1Clinical Pharmacokinetics Unit, Innsbruck Medical School, Innsbruck, Austria.

Artificial Organs
|January 26, 2006
PubMed

Insights

Albumin dialysis did not significantly alter liposomal amphotericin B levels in a patient with invasive mycosis. Plasma concentrations of liposomal amphotericin B remained higher than liberated forms during treatment.

Area of Science:

  • Pharmacology
  • Nephrology
  • Oncology

Background:

  • Extracorporeal blood purification techniques can unpredictably affect antimicrobial pharmacokinetics.
  • The impact of albumin dialysis on lipid-formulated drugs, specifically liposomal amphotericin B (AMB), remains unstudied.

Observation:

  • Plasma concentrations of liposomal and liberated AMB were measured in a patient undergoing albumin dialysis for cholestatic liver failure post-bone marrow transplant.
  • The patient received liposomal AMB for a suspected invasive fungal infection.

Findings:

  • Albumin dialysis did not lead to excessive elimination of AMB.
  • Plasma levels of liposomal AMB were consistently higher than liberated AMB.
  • Pharmacokinetic data were similar to those observed in patients undergoing hemofiltration or without extracorporeal blood purification.

Implications:

  • Albumin dialysis appears to be a safe method for AMB administration in patients requiring both treatments.
  • Further research is warranted to confirm these findings in a larger patient cohort.
  • Understanding drug-specific interactions with extracorporeal therapies is crucial for optimizing patient care.

Related Concept Videos

Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...